非手术鼻整形:5000例治疗回顾性分析
该研究回顾性分析了单一临床医生在2016年3月至2019年1月间使用透明质酸填充剂进行非手术鼻整形的5000例患者,最常见指征为鼻背驼峰(44%)。肿胀和红斑是约半数患者出现的自限性副作用,感染2例,局部皮肤坏死3例。结论认为由经验丰富的临床医生操作时,非手术鼻整形安全且美学效果良好。
要点
- 非手术鼻整形最常见指征为鼻背驼峰,占44%。
- 肿胀和红斑为常见自限性副作用,约见于半数患者。
- 感染2例,局部皮肤坏死3例,严重并发症少见。
核心结论
- 非手术鼻整形由经验丰富的临床医生操作时是安全的,并具有积极的美学效果。
研究设计与样本
- 回顾性研究,纳入2016年3月至2019年1月间接受非手术鼻整形的5000例患者,由单一临床医生使用透明质酸真皮填充剂按Harb描述的技术操作。
主要发现
- 最常见指征为鼻背驼峰,占44%。
- 肿胀和红斑是约半数患者出现的自限性副作用。
- 感染见于2例患者,局部皮肤坏死见于3例患者。
临床怎么用
- 需掌握鼻部解剖知识、接受全面培训并使用适当材料,以确保安全性和效果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Nonsurgical rhinoplasty with injectable dermal fillers has become an increasingly popular alternative to surgical procedures, in view of its relative low cost, convenience and rapid recovery, and low risk profile. The safety and efficacy of nonsurgical rhinoplasty remains a relatively contentious and ambiguous matter, given that there are few large-scale series reporting results or complications. This study reports the experience of a single clinician performing nonsurgical rhinoplasty in the largest cohort to date. METHODS: Patient demographics, indications, treatment details, and outcomes of patients treated between March of 2016 and January of 2019 were reviewed. The nonsurgical rhinoplasty technique described previously by Harb was used using hyaluronic acid dermal filler. RESULTS: Nonsurgical rhinoplasty was performed in 5000 patients. The commonest indication was dorsal hump (44 percent). Swelling and erythema were self-limiting side effects encountered in approximately half of patients. Infection was seen in two patients, and localized skin necrosis was observed in three patients. CONCLUSIONS: Nonsurgical rhinoplasty is a safe procedure with positive aesthetic results when performed by an experienced clinician. Knowledge of nasal anatomy, comprehensive training, and use of appropriate materials are key in ensuring safety and results. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.
引用
- Harb A, Brewster CT. The Nonsurgical Rhinoplasty: A Retrospective Review of 5000 Treatments. Plast Reconstr Surg. 2020. PMID: 32097303. doi:10.1097/PRS.0000000000006554
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。